Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...
In 1978, parvovirus—then common to cats—started infecting dogs in Europe. The virus spread quickly around the globe, killing ...
In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback